US$ 23.45
glp-1/gip dual agonist weight loss Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research Dual GIP/GLP-1 receptor agonists: New
Description
K., Reimann, F., & Liberles, S

Preoperative considerations of new long-acting glucagon-like peptide-1 receptor agonists in diabetes mellitus

Br J Anaesth

Use should always occur under clinical supervision with individualized evaluation, monitoring, and follow-up

Global economic burden of diabetes in adults: projections from 2015 to 2030
